Skip to Main Content

Paper Details

Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE.
Am Heart J
0
2023
Author NameAffiliation
Daniel Mu??ozVanderbilt University Medical Center
Saket GirotraUniversity of Texas Southwestern Medical Center
Steven M BradleyAllina Health Minneapolis Heart Institute
Robert A HarringtonStanford University School of Medicine
Russell L RothmanVanderbilt University Medical Center
Adrian F HernandezDuke Clinical Research Institute, Duke University
  • 1 - 6

Datasets

Release 1.2